SCHEMBL3785191

SCHEMBL3785191

Clc1cccc(Sc2ccccc2)c1Sc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.43
KDM4E B2RXH2 1/20 0.43
NSD2 O96028 1/20 0.43
MAPK1 P28482 1/20 0.43
HPGD P15428 1/20 0.41
PDE7A Q13946 2/20 0.41
SIRT1 Q96EB6 1/20 0.40
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
DHFR P00374 1/20 0.38
ALDH1A1 P00352 1/20 0.38
BLM P54132 1/20 0.38
PDE7B Q9NP56 1/20 0.38
PRMT1 Q99873 1/20 0.37
TUBB4A P04350 1/20 0.36
TUBB P07437 1/20 0.36
TUBA3C P0DPH7 1/20 0.36
TUBA1B P68363 1/20 0.36
TUBA4A P68366 1/20 0.36
TUBB4B P68371 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9557894 0.84 MAPT (0.50) MAPTKDM4ENSD2MAPK1HPGD
SCHEMBL3784489 0.82 PDE7A (0.50) MAPTKDM4ENSD2MAPK1HPGD
SCHEMBL1158036 0.81 CYP1A2 (0.45) MAPTKDM4ENSD2MAPK1HPGD
SCHEMBL3791257 0.78 MAPT (0.48) MAPTKDM4ENSD2MAPK1HPGD
SCHEMBL23418782 0.78 AKR1B1 (0.37) MAPTMEN1KMT2AALDH1A1LMNA
SCHEMBL3793122 0.78 TSHR (0.48) KDM4EHPGDMEN1KMT2ADHFR
SCHEMBL3791972 0.78 DHFR (0.44) MAPTKDM4ENSD2MAPK1HPGD
SCHEMBL18255782 0.78 CA12 (0.40) KDM4EPDE7AMEN1KMT2AALDH1A1
SCHEMBL11678416 0.75 MAPT (0.47) MAPTKDM4ENSD2MAPK1HPGD
SCHEMBL29042220 0.75 MAPT (0.43) MAPTKDM4ENSD2MAPK1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 MAPT 3312/4885KDM4E 2606/4885NSD2 3364/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.